- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Recurrent Pancreatic Adenocarcinoma
Total 19932 results
-
Chang Gung Memorial HospitalRecruitingMetastatic Pancreatic AdenocarcinomaTaiwan
-
University Health Network, TorontoRecruiting
-
Mandana Kamgar, MDRecruitingPancreatic Ductal AdenocarcinomaUnited States
-
John NeoptolemosInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest; Deutsches... and other collaboratorsNot yet recruiting
-
Vaccinex Inc.University of RochesterRecruitingMetastatic Pancreatic AdenocarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; Dana-Farber Cancer Institute; Sheba Medical Center; Shaare... and other collaboratorsRecruitingPancreatic Ductal AdenocarcinomaUnited States, Israel
-
HiberCell, Inc.Celldex TherapeuticsTerminatedMetastatic Pancreatic AdenocarcinomaUnited States
-
Cancer Insight, LLCBristol-Myers Squibb; Cancer Research Institute, New York City; Akamis BioActive, not recruitingMetastatic Pancreatic AdenocarcinomaUnited States
-
Theodor Bilharz Research InstituteCompletedPancreatic Ductal AdenocarcinomaEgypt
-
Centre hospitalier de l'Université de Montréal...SuspendedPancreatic Ductal AdenocarcinomaCanada
-
Ruijin HospitalActive, not recruitingPancreatic Ductal AdenocarcinomaChina
-
Spanish Cooperative Group for the Treatment of...CompletedMetastatic Pancreatic AdenocarcinomaSpain
-
Michele ReniActive, not recruitingPancreatic Ductal AdenocarcinomaItaly
-
Institut du Cancer de Montpellier - Val d'AurelleCompletedMetastatic Pancreatic AdenocarcinomaFrance
-
Pharmacyclics LLC.CompletedMetastatic Pancreatic AdenocarcinomaSpain, Italy, Korea, Republic of, United States, Belgium, United Kingdom, Germany, France
-
Georgetown UniversityNovartis; University of Texas Southwestern Medical Center; Cedars-Sinai Medical... and other collaboratorsUnknownMetastatic Pancreatic AdenocarcinomaUnited States
-
Oncolytics BiotechCompletedPancreatic AdenocarcinomaUnited States
-
Institut du Cancer de Montpellier - Val d'AurelleCompletedMetastatic Pancreatic AdenocarcinomaFrance
-
Lisa BaxRoche Pharma AG; Genentech, Inc.TerminatedPancreatic Ductal AdenocarcinomaUnited Kingdom
-
University of UtahActive, not recruitingProstate Adenocarcinoma | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Lymph Nodes | Recurrent Prostate Carcinoma | Oligometastasis | PSA FailureUnited States
-
National Cancer Institute (NCI)CompletedLung Carcinoid Tumor | Metastatic Digestive System Neuroendocrine Tumor G1 | Pancreatic Polypeptide Tumor | Multiple Endocrine Neoplasia Type 1 | Pancreatic Glucagonoma | Pancreatic Insulinoma | Somatostatin-Producing Neuroendocrine Tumor | Recurrent Digestive System Neuroendocrine Tumor G1 | Recurrent... and other conditionsUnited States
-
Fudan UniversityRecruitingPancreatic AdenocarcinomaChina
-
Fudan UniversityRecruitingPancreatic AdenocarcinomaChina
-
Eben RosenthalNational Cancer Institute (NCI)TerminatedPancreatic AdenocarcinomaUnited States
-
Ospedale San RaffaeleUnknownPancreatic AdenocarcinomaItaly
-
Roswell Park Cancer InstituteRecruitingPancreatic Ductal AdenocarcinomaUnited States
-
Genentech, Inc.BioNTech SERecruitingAdenocarcinoma, Pancreatic DuctalUnited States, Canada, United Kingdom
-
Amal TherapeuticsBoehringer IngelheimRecruitingPancreatic Ductal AdenocarcinomaUnited States, Switzerland
-
University Hospital, GrenobleNETRIS PharmaRecruitingPancreatic Ductal AdenocarcinomaFrance
-
CG Pharmaceuticals, IncRecruitingMetastatic Pancreatic AdenocarcinomaUnited States
-
University Health Network, TorontoRecruitingPancreatic Ductal AdenocarcinomaCanada
-
Centre Hospitalier Universitaire de BesanconTerminatedMetastatic Pancreatic AdenocarcinomaFrance
-
Washington University School of MedicineBristol-Myers Squibb; National Cancer Institute (NCI); National Institutes of... and other collaboratorsActive, not recruitingPancreatic Ductal AdenocarcinomaUnited States
-
UNICANCERCompletedMetastatic Pancreatic AdenocarcinomaFrance
-
Nanjing First Hospital, Nanjing Medical UniversityCompletedClinical Application of 68Ga-DOTA-NT-20.3 in the Early Diagnosis of Pancreatic Ductal AdenocarcinomaPancreatic Ductal AdenocarcinomaChina
-
Bracco Diagnostics, IncNational Institutes of Health (NIH)Active, not recruitingPancreatic Ductal AdenocarcinomaUnited States
-
Cancer Trials IrelandTerminated
-
Samsung Medical CenterCompletedPancreatic Ductal AdenocarcinomaKorea, Republic of
-
Parker Institute for Cancer ImmunotherapyBristol-Myers Squibb; Cancer Research Institute, New York City; Apexigen, Inc.CompletedMetastatic Pancreatic AdenocarcinomaUnited States
-
University Health Network, TorontoCompletedPancreatic Ductal AdenocarcinomaCanada
-
Gulam ManjiGenentech, Inc.; Halozyme TherapeuticsTerminatedStudy Evaluating NEOadjuvant Immunotherapy in Resectable PANCreatic Ductal Adenocarcinoma (NEOiPANC)Pancreatic Ductal AdenocarcinomaUnited States
-
CCTU- Cancer ThemeCelgeneCompletedPancreatic Adenocarcinoma MetastaticUnited Kingdom
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; Chang Gung Memorial Hospital; National Cheng-Kung...Completed
-
Clovis Oncology, Inc.CompletedMetastatic Pancreatic AdenocarcinomaUnited States, Belgium, Canada, Australia, United Kingdom, Germany, Italy, Argentina, Russian Federation, France, Brazil, Sweden, Norway, Netherlands, Ukraine
-
Massachusetts General HospitalRecruitingPancreatic Ductal AdenocarcinomaUnited States
-
University Hospital, BordeauxServierCompleted
-
Edward NelsonCompletedPancreatic Cancer | Resectable Pancreatic AdenocarcinomaUnited States
-
Cornerstone PharmaceuticalsWithdrawnMetastatic Pancreatic AdenocarcinomaUnited States
-
Sun Yat-sen UniversityRecruitingHepatocellular Carcinoma | Liver Cancer | Recurrent Tumor | Microwave Ablation | LenvatinibChina
-
Lion TCR Pte. Ltd.WithdrawnRecurrent Hepatocellular CarcinomaSingapore, China